Opinion
Video
Author(s):
Experts on non–muscle invasive bladder cancer discuss promising developments in the overall treatment landscape, highlighting potentially practice-changing clinical research.
Challenges in plasmacytoid urothelial carcinoma underscore need for novel treatment options
Bladder Cancer Awareness Month: Dr. Kamat highlights the state of bladder cancer care
New Drug Application initiated with FDA for TAR-200 for NMIBC
Dr. Lutz on sexual dysfunction, performance anxiety, and Peyronie's disease
The economics of bladder cancer in the US: Increasing costs and unsustainable patterns
CREST: Sasanlimab hits primary end point of EFS for NMIBC